SCHEMBL7547677

SCHEMBL7547677

COc1cccc(-c2cncc(-c3cn(CCCN(C)C)c4cccnc34)c2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.49
GSK3B P49841 2/20 0.44
QPCT Q16769 1/20 0.40
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
HTR6 P50406 2/20 0.38
MKNK1 Q9BUB5 1/20 0.38
TOP1 P11387 1/20 0.37
FLT3 P36888 1/20 0.37
MAOB P27338 1/20 0.37
PRKD1 Q15139 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
BACE1 P56817 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2B Q13224 1/20 0.37
BRD9 Q9H8M2 1/20 0.36
BRD7 Q9NPI1 1/20 0.36
ROCK2 O75116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549825 0.91 KDR (0.51) KDRGSK3BQPCTHTR6FLT3
SCHEMBL7548397 0.87 KDR (0.57) KDRGSK3BHTR6TDP1PIM1
SCHEMBL7976532 0.87 KDR (0.51) KDRGSK3BHTR6GRIN1GRIN2B
SCHEMBL7550679 0.86 KDR (0.67) KDRGSK3BQPCTFLT3PRKD1
SCHEMBL7986865 0.85 KDR (0.50) KDRGSK3BQPCTBACE1
SCHEMBL7550710 0.85 KDR (0.52) KDRGSK3BQPCT
SCHEMBL7987071 0.84 KDR (0.56) KDRGSK3BQPCTHTR6FLT3
SCHEMBL7547036 0.84 FLT1 (0.51) KDRPDE4APDE4BPDE4CPDE4D
SCHEMBL7986680 0.83 KDR (0.49) KDRGSK3BQPCTFLT3PRKD1
SCHEMBL7548728 0.83 KDR (0.52) KDRGSK3BHTR6PIM1HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed